Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
In gyrate atrophy of the choroid and retina with hyperornithinaemia (GA), a genetically determined deficiency of ornithine delta-aminotransferase activity leads to high ornithine concentrations in body fluids. GA is characterized by centripetally progressing retinal and choroidal destruction and selective atrophy with tubular aggregates in type II skeletal muscle fibres. These findings have been suggested to be mediated by hyperornithinaemia-induced deficiency of high-energy creatine phosphate. As abnormal brain magnetic resonance images and electroencephalograms are found in another disorder of creatine metabolism, guanidinoacetate methyltransferase deficiency, we investigated the central nervous system involvement in GA, which seems to be associated with a milder degree of phosphocreatine deficiency. We compared 23 untreated GA patients with age-matched healthy controls, and with 9 patients who had received creatine or creatine precursor supplementation daily for several years. The mean age of the patients (32 +/- 18 years) was similar to that of the controls (36 +/- 22 years). The MRI or EEG findings of the patients on creatine supplementation did not differ from those of the untreated group. Brain MRI revealed degenerative lesions in the white matter in 50% of the GA patients, and 70% of the patients had premature atrophic changes, with a striking increase in the number of Virchow's spaces. Of the patients whose EEG was recorded, 58% had abnormal slow background activity, focal lesions or high-amplitude beta rhythm (> 50 microV). The EEG findings were not associated with the MRI changes or with the age or the sex of the patients. Early degenerative and atrophic brain changes and abnormal EEG are thus features of GA, in addition to the well-characterized eye and muscle manifestations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results from studies spanning up to 72 months in this patient population indicate that creatine supplementation can slow disease progression while also helping to maintain levels of type II skeletal muscle fiber content [68,69].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [68]
Citations
Cites
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
Holt, I. J., Harding, A. E., Petty, R., & MORGAN-HUGHES, J. A. (1990) · PubMed · Cited by 1,005
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Current practice of clinical electroencephalography
Hughes, J. R. (1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90008-8 · Cited by 414
Cerebral structure on MRI, Part I: Localization of age-related changes
Jernigan, T. L., Archibald, S. L., Berhow, M. T., Sowell, E. R., Foster, D. S., & Hesselink, J. R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90210-d · Cited by 388 · cited 1×
“Owing to the reduced cortical grey matter volume, the ventricular and sulcal sizes increase gradually before the age of 60 years, and then more rapidly ( Jernigan et al 1990, 1991 ).”
BackgroundLarge Virchow-Robin spaces: MR-clinical correlation.
(1989) · PubMed Central · Cited by 331
Mitochondrial Encephalomyopathies
DiMauro, S., & Moraes, C. T. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540110075008 · Cited by 301
Gyldensted, C. (1977) · Neuroradiology · doi:10.1007/bf00496982 · Cited by 280 · cited 1×
“To quantify the degree of brain atrophy, several indices were acquired of the dimensions of the cerebrospinal Ñuid space, brain and skull using a method previously applied for computed tomography of the brain (Gyllensted 1977 ; Meese et al 1980).”
MethodJernigan, T. L. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010035015 · Cited by 257
RAISED PLASMA-ORNITHINE AND GYRATE ATROPHY OF THE CHOROID AND RETINA
Simell, O., & Takki, K. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90667-3 · Cited by 251 · cited 1×
“Several mutations in the gene encoding ornithine d-aminotransferase (EC 2.6.1.13 ; OAT) abolish the enzyme activity and lead to a 10- to 20-fold increase in the plasma ornithine concentration (Simell and Takki 1973 ; Kaiser-Kupfer et al 1981 ; Takki and Milton 1981 ; Valle and Simell 1995).”
BackgroundInfluentialSelf-citationStöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina
Sipilä, I., Rapola, J., Simell, O., & Vannas, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041503 · Cited by 181
Self-citationCT evaluation of the CSF spaces of healthy persons
Meese, W., Kluge, W., Grumme, T., & Hopfenm�ller, W. (1980) · Neuroradiology · doi:10.1007/bf00342387 · Cited by 180
Extracellular creatine regulates creatine transport in rat and human muscle cells.
Loike, J. D., Zalutsky, D. L., Kaback, E., Miranda, A. F., & Silverstein, S. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.807 · Cited by 170 · cited 1×
“Neurons lack the high-capacity sodiumdependent creatine transport system that operates in the myocyte (Schloss et al 1994; Loike et al 1988; Moe ller et al 1989), and a major part of the creatine of the grey matter is thus probably synthesized locally (Holtzman et al 1996, 1997; Tsuji et al 1996).”
BackgroundSchulze, A., Hess, T., Wevers, R., Mayatepek, E., Bachert, P., Marescau, B., Knopp, M. V., De Deyn, P. P., Bremer, H. J., & Rating, D. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70075-1 · Cited by 170 · cited 2×
“…guanidinoacetate methyltransferase deÐciency, which causes almost complete depletion of endogenous creatine and phosphocreatine, also leads to grave neurological symptoms and abnormalities of brain structure and function (Sto ckler et al 1994, 1996 ; Ganesan et al 1997 ; Schulze et al 1997).”
BackgroundJackson, M. J., Schaefer, J. A., Johnson, M. A., Morris, A. A. M., Turnbull, D. M., & Bindoff, L. A. (1995) · Brain · doi:10.1093/brain/118.2.339 · Cited by 166
Age Dependent White Matter Lesions and Brain Volume Changes in Healthy Volunteers
Christiansen, P., Larsson, H. B. W., Thomsen, C., Wieslander, S. B., & Henriksen, O. (1994) · Acta Radiologica · doi:10.1177/028418519403500203 · Cited by 136
The Natural History of Gyrate Atrophy of the Choroid and Retina
Takki, K. K., & Milton, R. C. (1981) · Ophthalmology · doi:10.1016/s0161-6420(81)35031-3 · Cited by 132 · cited 2×
“Characteristic chorioretinal degeneration and centripetally progressing constriction of the visual Ðelds dominate the clinical course of GA (Takki and Milton 1981).”
BackgroundGyrate Atrophy of the Choroid and Retina
Vannas-Sulonen, K., Sipilä, I., Vannas, A., Simell, O., & Rapola, J. (1985) · Ophthalmology · doi:10.1016/s0161-6420(85)34098-8 · Cited by 124 · cited 1×
“However, creatine supplementation does not seem to alter the gradual slow progression of the eye manifestations in GA (Vannas-Sulonen et al 1985), and we have found that EEG and MRI abnormalities were similarly present in patients on creatine supplementation and in patients not receiving…”
BackgroundSelf-citationGenetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia.
Takki, K. K., & Simell, O. (1974) · British Journal of Ophthalmology · doi:10.1136/bjo.58.11.907 · Cited by 109
Self-citationGuanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108 · cited 4×
“In patients with guanidinoacetate methyltransferase de—ciency, high-dose creatine therapy nearly normalizes biochemical and magnetic resonance spectroscopy —ndings, and the patients show marked clinical improvement (Stoe ckler et al 1996; Ganesan et al 1997 ).”
BackgroundInfluentialSchloss, P. D., Mayser, W., & Betz, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1093 · Cited by 107 · cited 1×
“Neurons lack the high-capacity sodiumdependent creatine transport system that operates in the myocyte (Schloss et al 1994 ; Loike et al 1988 ; Mo ller et al 1989), and a major part of the creatine of the grey matter is thus probably synthesized locally (Holtzman et al 1996, 1997 ; Tsuji et al 1996).”
BackgroundPrevalence and clinical significance of dilated Virchow-Robin spaces in childhood.
Rollins, N. K., Deline, C., & Morriss, M. C. (1993) · Radiology · doi:10.1148/radiology.189.1.7690491 · Cited by 92
Creatine Transport in Cultured Cells of Rat and Mouse Brain
Möller, A., & Hamprecht, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09154.x · Cited by 90
Sipilä, I., Simell, O., Rapola, J., Sainio, K., & Tuuteri, L. (1979) · Neurology · doi:10.1212/wnl.29.7.996 · Cited by 90 · cited 1×
“By puberty, type II muscle Ðbres show progressive atrophy, and tubular aggregates accumulate in the a†ected cells (Sipila et al 1979 ; Valtonen et al 1996).”
BackgroundSelf-citationSipilä, I. (1980) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(80)90194-1 · Cited by 87 · cited 1×
“One theory of the pathogenesis of GA involves inhibition of creatine biosynthesis by hyperornithinaemia (Sipila 1980 ; Sipila et al 1980), resulting in a deÐciency of phosphocreatine, which is essential for the storage and transmission of phosphate-bound energy in muscle and brain (Holtzman et al…”
BackgroundOcular Clinicopathologic Study of the Mitochondrial Encephalomyopathy Overlap Syndromes
Chang, T. S. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090090106028 · Cited by 74 · cited 1×
“…1990), the KearnsÈSayre syndrome (Di Mauro and Moraes 1993) and the MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) (Chang et al 1993) often present with a triad of pigmentary retinopathy combined with muscle and central nervous system involvement.”
BackgroundThe clinical and genetic correlates of MRI findings in myotonic dystrophy
Bachmann, G. W., Damian, M. S., Koch, M. C., Schilling, G., Fach, B., & Stöppler, S. (1996) · Neuroradiology · doi:10.1007/s002340050322 · Cited by 71 · cited 2×
“In childhood, such changes are occasionally seen in normal subjects, and occur in association with functional neuropsychiatric diseases (Rollins et al 1993) or heterogeneous neurological or neuromuscular disorders ( Bachmann et al 1996; Steiner et al 1996).”
BackgroundReduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia
Näntö–Salonen, K., Komu, M., Lundbom, N., Heinänen, K., Alanen, A., Sipilä, I., & Simell, O. (1999) · Neurology · doi:10.1212/wnl.53.2.303 · Cited by 63
Self-citationGyrate Atrophy of the Choroid and Retina with Hyperornithinemia
McCulloch, C., & Marliss, E. B. (1975) · American Journal of Ophthalmology · doi:10.1016/0002-9394(75)90335-9 · Cited by 60
Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia
Heinänen, Näntö‐Salonen, Komu, Erkintalo, Alanen, Heinonen, Pulkki, Nikoskelainen, Sipilä, & Simell (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00569.x · Cited by 57
Self-citationSystemic Manifestations of Gyrate Atrophy of the Choroid and Retina
Kaiser‐Kupfer, M. I., Kuwabara, T., Askanas, V., Brody, L., Takki, K. K., Dvoretzky, I., & Engel, W. K. (1981) · Ophthalmology · doi:10.1016/s0161-6420(81)35030-1 · Cited by 54
Hypomelanosis of Ito and brain abnormalities: MRI findings and literature review
Steiner, J. I., Adamsbaum, C., Desguerres, I., Lalande, G., Raynaud, R., Ponsot, G., & Kalifa, G. (1996) · Pediatric Radiology · doi:10.1007/bf01396196 · Cited by 47
EEG findings in children and adolescents with mitochondrial encephalomyopathies: A study of 25 cases
Tulinius, M., & Hagne, I. (1991) · Brain and Development · doi:10.1016/s0387-7604(12)80024-6 · Cited by 45 · cited 1×
“…metabolism are reÑected as EEG abnormalities in most mitochondriopathies with clinical central nervous system manifestations (Jackson et al 1995 ; Tulinius and Hagne 1991), and are often found in mitochondrial myopathies with no clinical signs of central nervous system involvement (Smith and…”
BackgroundSipilä, I., Simell, O., & Arjomaa, P. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109905 · Cited by 43 · cited 1×
“One theory of the pathogenesis of GA involves inhibition of creatine biosynthesis by hyperornithinaemia (Sipila 1980 ; Sipila et al 1980), resulting in a deÐciency of phosphocreatine, which is essential for the storage and transmission of phosphate-bound energy in muscle and brain (Holtzman et al…”
BackgroundSelf-citationIn vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog
Holtzman, D., Meyers, R., O'Gorman, E., Khait, I., Wallimann, T., Allred, E., & Jensen, F. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.5.c1567 · Cited by 40
NONSPECIFIC LEUKOENCEPHALOPATHY ASSOCIATED WITH AGING
Golomb, J., Kluger, A., Gianutsos, J., Ferris, S. H., de Leon, M. J., & George, A. E. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00274-6 · Cited by 39
Heinänen, Näntö‐Salonen, Komu, Erkintalo, Heinonen, Pulkki, Valtonen, Nikoskelainen, Alanen, & Simell (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00467.x · Cited by 30
Tsuji, M. K., Mulkern, R. V., Cook, C. U., Meyers, R., & Holtzman, D. H. (1996) · Brain Research · doi:10.1016/0006-8993(95)01229-x · Cited by 22 · cited 1×
“Neurons lack the high-capacity sodiumdependent creatine transport system that operates in the myocyte (Schloss et al 1994; Loike et al 1988; Moe ller et al 1989), and a major part of the creatine of the grey matter is thus probably synthesized locally (Holtzman et al 1996, 1997; Tsuji et al 1996 ).”
BackgroundHistopathological Changes of Chronic Alcoholism
Miyakawa, T., Hattori, E., Shikai, I., Shimoji, A., Nagatoshi, K., & Suzuki, T. (1977) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1977.tb02726.x · Cited by 21 · cited 1×
“Abnormally wide spaces have been associated with hypertension, dementia (Heier et al 1989) and chronic alcoholism ( Miyakawa et al 1977 ).”
BackgroundEEG and evoked potential findings in mitochondrial myopathies
Smith, S. J. M., & Harding, A. E. (1993) · Journal of Neurology · doi:10.1007/bf00839969 · Cited by 19
Phosphocreatine and Creatine H Kinase in Piglet Cerebral Gray and White Matter in situ
Holtzman, D. H., Mulkern, R. V., Tsuji, M. K., Cook, C. U., & Meyers, R. (2007) · Developmental Neuroscience · doi:10.1159/000111451 · Cited by 17 · cited 2×
“Neurons lack the high-capacity sodiumdependent creatine transport system that operates in the myocyte (Schloss et al 1994 ; Loike et al 1988 ; Mo ller et al 1989), and a major part of the creatine of the grey matter is thus probably synthesized locally (Holtzman et al 1996, 1997 ; Tsuji et al 1996).”
BackgroundValtonen, M., Näntö‐Salonen, K., Heinänen, K., Alanen, A., Kalimo, H., & Simell, O. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799162 · Cited by 15
Self-citationGyrate atrophy of the choroid and retina: clinical, ophthalmologic, and biochemical considerations.
McCulloch, C., & Marliss, E. B. (1975) · Europe PMC (PubMed Central) · Cited by 11
Continuous, Generalized, High-Voltage Fast Activity and FIRDA in Two Children
Mutoh, K., Okuno, T., Ito, M., Fujii, T., & Mikawa, H. (1992) · Clinical Electroencephalography · doi:10.1177/155005949202300205 · Cited by 11
Infantile neuroaxonal dystrophy: Diagnosis by skin biopsy
Özmen, M., Çalışkan, M., Goebel, H. H., & Apak, S. (1991) · Brain and Development · doi:10.1016/s0387-7604(12)80059-3 · Cited by 7
Myopathy in hyperornithinemic gyrate atrophy of choroid and retina.
Shapira, Y., Yatziv, S., Merin, S., Statter, M., & Yarom, R. (1981) · PubMed · Cited by 5
Research works printed but not linked: 1
- Valle D, 1995, The Metalobic and Molecular Bases of Inherited Disease, 1147
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Wyss, M., & Schulze, A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00088-x · Cited by 175
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
“While GA patients may develop with normal intelligence, electroencephalography and magnetic resonance imaging analysis have, however, demonstrated unspecific abnormalities and premature degenerative changes in CNS (Näntö-Salonen et al. 1999; Valtonen et al. 1999).”
BackgroundKreider, R. B., Melton, C., Rasmussen, C. J., Greenwood, M., Lancaster, S., Cantler, E. C., Milnor, P., & Almada, A. L. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022469320296 · Cited by 181
“There is also recent evidence that creatine supplementation may provide therapeutic benefit for patients with a variety of metabolic disorders [11–15], neuromuscular diseases [16–21], as well hasten recovery following immobilization [22].”
Background
Metadata
- Authors
- Valtonen, M., Näntö‐Salonen, K., Jääskeläinen, S., Heinänen, K., Alanen, A., Heinonen, O. J., Lundbom, N., Erkintalo, M., & Simell, O.
- Affiliations
- University of Turku (FI)
- Sports and Exercise Medicine Unit, Department of Physiology University of Turku Turku Finland
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 22
- Issue
- 8
- Pages
- 855-866
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W215452445
- Cited by
- 46
- References
- 46
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 3
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Signe ja Ane Gyllenbergin Säätiö
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- gyrate atrophy of the choroid and retina, central nervous system involvement, white matter degeneration, creatine supplementation, creatine metabolism, guanidinoacetate methyltransferase deficiency, EEG abnormalities, brain MRI
- MeSH terms
- Adolescent, Adult, Aged, Brain, Central Nervous System, Child, Child, Preschool, Choroid, Creatine, Electroencephalography, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Ornithine, Ornithine-Oxo-Acid Transaminase, Retina, Gyrate Atrophy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.